Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Autoriseret fysioterapeut NDH Holding ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   10.1% 19.4% 17.5% 11.8% 11.1% 8.7% 19.6% 19.6%   Credit score (0-100)   26 6 8 19 21 28 6 6   Credit rating   BB B B BB BB BB B B   Credit limit (kDKK)   0.0 -0.0 -0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -5.0 -3.8 -4.1 -4.4 -6.4 -4.8 0.0 0.0   EBITDA   -5.0 -3.8 -4.1 -4.4 -6.4 -4.8 0.0 0.0   EBIT   -5.0 -3.8 -4.1 -4.4 -6.4 -4.8 0.0 0.0   Pre-tax profit (PTP)   -5.0 -85.6 -1.3 79.4 41.3 158.3 0.0 0.0   Net earnings   -5.0 -85.6 -1.3 79.4 41.3 158.3 0.0 0.0   Pre-tax profit without non-rec. items   -5.0 -85.6 -1.3 79.4 41.3 158 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   14.3 -71.2 -72.5 6.9 48.2 206 156 156   Interest-bearing liabilities   83.9 92.1 75.1 82.8 85.5 17.9 0.0 0.0   Balance sheet total (assets)   102 24.6 6.4 93.4 137 228 156 156   Net Debt   55.3 67.5 75.1 82.8 85.5 17.9 -156 -156     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -5.0 -3.8 -4.1 -4.4 -6.4 -4.8 0.0 0.0   Gross profit growth   53.4% 24.6% -10.0% -6.1% -46.9% 26.1% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   102 25 6 93 137 228 156 156   Balance sheet change%   341.7% -75.9% -74.0% 1,362.3% 47.1% 66.2% -31.5% 0.0%   Added value   -5.0 -3.8 -4.1 -4.4 -6.4 -4.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 -4.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -8.0% 70.4% -12.0% -106.1% 49.4% 81.6% 0.0% 0.0%   ROI %   -8.5% -81.1% 2.7% 100.3% 40.4% 90.1% 0.0% 0.0%   ROE %   -29.7% -439.6% -8.1% 1,195.4% 149.9% 124.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   14.1% -74.3% -91.9% 7.4% 35.1% 90.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1,113.2% -1,800.0% -1,821.7% -1,891.7% -1,330.1% -377.5% 0.0% 0.0%   Gearing %   585.5% -129.3% -103.6% 1,200.0% 177.5% 8.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 9.6% 4.2% 4.1% 4.5% 5.8% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.3 0.3 0.0 0.0 0.4 5.7 0.0 0.0   Current Ratio   0.3 0.3 0.0 0.0 0.4 5.7 0.0 0.0   Cash and cash equivalent   28.5 24.6 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -59.1 -71.2 -78.9 -86.5 -49.2 103.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0